CredoScientia - Bibliothèque

[A Case of Myocardial Dysfunction in a Patient with Recurrent Colon Cancer Treated with Bevacizumab].

An 86-year-old man underwent laparoscopic ileocecal resection with lymph node dissection(pT3N0M0, Stage Ⅱa, Ly1a, V1a). The patient did not receive any adjuvant chemotherapy. Two years later, the pati…

Thérapies de Conversion

Tamesa, T., Umeno, H., Kinoshita, M., Kanesada, K., Kondo, J., Hamada, Y., & Gondo, T. (2025). [A Case of Myocardial Dysfunction in a Patient with Recurrent Colon Cancer Treated with Bevacizumab].. Gan To Kagaku Ryoho, 52(3), 266-268.

01/03/2025 Lire →

A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014-2023.

BACKGROUND: With advancements in drug therapy, local treatments, and evolving concepts, conversion therapy has shown benefits for patients initially diagnosed with unresectable hepatocellular carcinom…

Thérapies de Conversion

Chen, Q. F., Jiang, X. Y., Chen, M. S., Lyu, N., & Zhao, M. (2025). A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014-2023.. Ann Surg Open, 6(1), e562. https://doi.org/10.1097/AS9.0000000000000562

01/03/2025 Lire →

An Inclusive History of LGBTQ+ Aversion Therapy: Past Harms and Future Address in a UK Context.

From the 1950s, aversion therapy gained an international foothold as a behaviourist means to alter what was then considered 'deviant' behaviour. Using primary research by psychologists, psychiatrists …

Thérapies de Conversion

Davison, K., Hubbard, K., Marks, S., Spandler, H., & Wynter, R. (2025). An Inclusive History of LGBTQ+ Aversion Therapy: Past Harms and Future Address in a UK Context.. Rev Gen Psychol, 29(1), 33-48. https://doi.org/10.1177/10892680241289904

01/03/2025 Lire →

Efficacy and conversion outcome of chemotherapy combined with PD-1 inhibitor for patients with unresectable or recurrent gallbladder carcinoma: a real-world exploratory study.

BACKGROUND: Gallbladder carcinoma (GBC) is an extremely aggressive tumor of the biliary tract with a bleak prognosis, and the evidence supporting the benefit of available systemic therapy for advanced…

Thérapies de Conversion

Liu, Q. Q., Yan, J., Ye, Y. F., Yang, C. N., Chen, Z. J., Lin, H. M., Zhang, Z. T., & Zhang, R. (2025). Efficacy and conversion outcome of chemotherapy combined with PD-1 inhibitor for patients with unresectable or recurrent gallbladder carcinoma: a real-world exploratory study.. World J Surg Oncol, 23(1), 69. https://doi.org/10.1186/s12957-025-03703-7

28/02/2025 Lire →

[Advances of neoadjuvant and conversion therapy with PD-1 inhibitors in gastric cancer].

Gastric cancer (GC) is one of the most common malignant tumors of the digestive system in China. With the progress of immunotherapy research, programmed death receptor-1 (PD-1) inhibitor-based combina…

Thérapies de Conversion

Tang, Y. F., Zhou, B. Q., Dai, S. M., Wen, B. B., Liu, J. X., Li, L. Y., & Fan, R. F. (2025). [Advances of neoadjuvant and conversion therapy with PD-1 inhibitors in gastric cancer].. Zhonghua Wei Chang Wai Ke Za Zhi, 28(2), 217-224. https://doi.org/10.3760/cma.j.cn441530-20240728-00263

25/02/2025 Lire →

Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China.

With the advances in transplant oncology in recent years, the role of liver transplantation has expanded to make curative treatment a possibility for a wider patient population. We highlight strategie…

Thérapies de Conversion

Ho, K., & Chan, A. (2025). Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China.. Hepatobiliary Pancreat Dis Int, 24(1), 45-49. https://doi.org/10.1016/j.hbpd.2024.09.005

01/02/2025 Lire →

Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is typically diagnosed at intermediate to advanced stage, making surgical treatment unfeasible. Conversion therapy aims to reduce tumor stage, improve hepatic resection …

Thérapies de Conversion

Wu, F., Kuang, X., Deng, S., Qi, S., Xiong, J., Zhao, B., Li, C., Tan, S., Kang, Q., Xiao, H., Tan, X., Wu, G. L., Yang, Q., & Chen, G. (2025). Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma.. Mater Today Bio, 30, 101442. https://doi.org/10.1016/j.mtbio.2024.101442

01/02/2025 Lire →

HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion.

BACKGROUND/OBJECTIVE: The treatment strategy for hepatocellular carcinoma (HCC) with Vp4 (main trunk) portal vein tumor thrombosis (PVTT) remains controversial due to the dismal prognosis. We aimed to…

Thérapies de Conversion

Tang, S., Shi, F., Xiao, Y., Cai, H., Ma, P., Zhou, Y., Wu, Z., Chen, S., & Guo, W. (2025). HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion.. Hepatol Int, 19(1), 106-117. https://doi.org/10.1007/s12072-024-10762-7

01/02/2025 Lire →

Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments.

The benefit of resection of liver metastases depends on primary diseases. Neuroendocrine tumors are associated with favorable prognosis after resection of liver metastases. Gastric cancer has worse tu…

Thérapies de Conversion

Kawaguchi, Y., De, B. e. l. l. i. s. . M., Panettieri, E., Duwe, G., & Vauthey, J. N. (2025). Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments.. Hematol Oncol Clin North Am, 39(1), 207-220. https://doi.org/10.1016/j.hoc.2024.08.009

01/02/2025 Lire →

Do we want to know?

The weak evidence base and profound consequences of gender-affirming interventions for youth call for a particularly sensitive and complex psychoanalytic exploration. However, prohibitions on knowing …

Thérapies de Conversion

D'Angelo, R. (2025). Do we want to know?. Int J Psychoanal, 106(1), 82-108. https://doi.org/10.1080/00207578.2024.2395964

01/02/2025 Lire →

Moving Forward With Pride: LGBTQ+ Health and Contemporary Rights Movements in Asia.

As Pride marches are celebrated globally in June, stigma and discriminatory laws against LGBTQ+ individuals remain prevalent in over a third of countries, potentially worsening health disparities amon…

Thérapies de Conversion

Alibudbud, R. (2025). Moving Forward With Pride: LGBTQ+ Health and Contemporary Rights Movements in Asia.. Am J Health Promot, 39(2), 197-199. https://doi.org/10.1177/08901171241279783

01/02/2025 Lire →

Mental Health Practitioners' Knowledge of LGBTQA+ Conversion Practices and Their Perceptions of Impacts on Survivors.

The aims of this study were to identify Australian mental health practitioners' knowledge of what LGBTQA+ conversion practices are and their perceptions of impacts on survivors. We interviewed 18 ment…

Thérapies de Conversion

Anderson, J. R., Jones, T. W., Power, J., Jones, T. M., Despott, N., Pallotta-Chiarolli, M., & Gurtler, P. (2025). Mental Health Practitioners' Knowledge of LGBTQA+ Conversion Practices and Their Perceptions of Impacts on Survivors.. J Homosex, 72(2), 213-227. https://doi.org/10.1080/00918369.2024.2319615

28/01/2025 Lire →